ATF5 itself has been related to cell enhanced invasion of fibrosarcoma and breast cancer cells [55], and its therapeutic targeting strongly reduced cancer cell survival, except for pancreatic cancer and CRC [56,57]. Here, ATF5 is linked to colorectal carcinoma.